188 related articles for article (PubMed ID: 37507049)
1. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.
Lizotte F; Rousseau M; Denhez B; Lévesque D; Guay A; Liu H; Moreau J; Higgins S; Sabbagh R; Susztak K; Boisvert FM; Côté AM; Geraldes P
Kidney Int; 2023 Oct; 104(4):787-802. PubMed ID: 37507049
[TBL] [Abstract][Full Text] [Related]
2. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
3. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
[TBL] [Abstract][Full Text] [Related]
4. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
[TBL] [Abstract][Full Text] [Related]
5. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
6. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
8. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
9. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
10. Enhanced SHP-1 Expression in Podocyturia Is Associated with Kidney Dysfunction in Patients with Diabetes.
Lizotte F; Robillard S; Lavoie N; Rousseau M; Denhez B; Moreau J; Higgins S; Sabbagh R; Côté AM; Geraldes P
Kidney360; 2022 Oct; 3(10):1710-1719. PubMed ID: 36514736
[TBL] [Abstract][Full Text] [Related]
11. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin.
Zhang Y; Fukusumi Y; Kayaba M; Nakamura T; Sakamoto R; Ashizawa N; Kawachi H
Nefrologia (Engl Ed); 2021; 41(5):539-547. PubMed ID: 36165136
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.
Ishizaka M; Gohda T; Takagi M; Omote K; Sonoda Y; Oliva Trejo JA; Asao R; Hidaka T; Asanuma K; Horikoshi S; Tomino Y
Biochem Biophys Res Commun; 2015 Nov; 467(3):549-55. PubMed ID: 26435502
[TBL] [Abstract][Full Text] [Related]
15. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979
[TBL] [Abstract][Full Text] [Related]
16. Saxagliptin attenuates glomerular podocyte injury by increasing the expression of renal nephrin and podocin in type 2 diabetic rats.
Hu Y; Ye S; Xing Y; Lv L; Hu W; Zhou W
Acta Diabetol; 2020 Mar; 57(3):279-286. PubMed ID: 31535208
[TBL] [Abstract][Full Text] [Related]
17. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
18. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
[TBL] [Abstract][Full Text] [Related]
20. [Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].
Chen JX; Fang QJ; Wan YG; Liu YL; Wang Y; Wu W; Tu Y; Wang MZ; Wang DG; Ge HT
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4137-4146. PubMed ID: 37802782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
